The diagnosis of depression will soon be revealed on a simple blood test.

In a few years it will be easier to diagnose depression: a simple blood test will suffice. This won't come right away, but in five years. And the test will also help personalize diagnosis and treatment from depression, as well as to find out who is most [...]
In a few years it will be easier to diagnose depression: a simple blood test will suffice.
This won't come right away, but in five years. And the test will also help personalize diagnosis and treatment from depression, as well as to find out who is most endangered to experience the disease.
Requesting Summary
The idea is supported by Dario Aspes and Graziano Pinna of the University of Illinois, and is published in the magazine Expert Review of Proteomics and presented in Dallas at X Conference III of Italian scholars in the world. <x) Practically, it will be enough to measure the blood level of molecules such as the neurosteroids produced in the brain, but they are also present in the blood and are changed by stress.
Also in post traumatic stress
Such levels may indicate mood concerns in a person and psychiatric illness, such as depression and post-traumatic stress disorder (Ptsd). In this regard, a blood test is taking place in the laboratory that requires various molecules, at least 20, whose concentration is essential for diagnosing depression or to find out who is prone to post traumatic stress. The test will also show who among the depressions can take advantage of certain drugs, helping to regulate therapies”.
Purposes for the Future
At present psychiatric disorders such as depression are diagnosed through patient questionnaires and are based on symptoms; having a testing based on multiple indicators that track each patient's biofirmation would be a revolution in both the diagnostic and therapeutic fields. Moreover, it can also help identify different types of patients, organise more targeted clinical trials, and produce more precise drugs.










